X0303 4 2009-12-31 0 0001339455 Somaxon Pharmaceuticals, Inc. SOMX 0001024004 HALE DAVID F C/O SOMAXON PHARMACEUTICALS 3830 VALLEY CENTRE DRIVE, SUITE 705-461 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2009-12-31 4 A 0 25926 0.00 A 37375 D Common Stock 436014 I By Hale Family Trust UTD 2/10/86 These shares are represented by restricted stock units ("RSUs"). These RSUs will vest upon the first date included within an open trading window under the Company's Insider Trading Policy following the first commercial sale of Silenor(R) in the United States, subject to the director's continued service to the Company on such date. Reflects the forfeiture on December 31, 2009 of 27,523 restricted stock units that expired unvested. The vesting of such restricted stock units depended upon the Company raising aggregate proceeds of $25 million from one or more financing or strategic transactions during 2009, and that condition was not met. /s/ Matthew Onaitis, Attorney-in-fact 2010-01-05